A combination of rituximab, cyclophosphamide and dexamethasone effectively treats immune cytopenias of chronic lymphocytic leukemia.
about
Non-invasive Imaging of Sendai Virus Infection in Pharmacologically Immunocompromised Mice: NK and T Cells, but not Neutrophils, Promote Viral Clearance after Therapy with Cyclophosphamide and DexamethasoneRapid clearance of rituximab may contribute to the continued high incidence of autoimmune hematologic complications of chemoimmunotherapy for chronic lymphocytic leukemia.Old DAT and new data: positive direct antiglobulin test identifies a subgroup with poor outcome among chronic lymphocytic leukemia stage A patients.Management of autoimmune cytopenia complicating chronic lymphocytic leukemia.Treatment of autoimmune cytopenia complicating progressive chronic lymphocytic leukemia/small lymphocytic lymphoma with rituximab, cyclophosphamide, vincristine, and prednisone.The challenge of treating complex autoimmune cytopenias in chronic lymphocytic leukemia.Autoimmune complications in chronic lymphocytic leukaemia (CLL).Rituximab-cyclophosphamide-dexamethasone combination in the management of autoimmune cytopenias associated with chronic lymphocytic leukemia.Chronic lymphocytic leukemia and autoimmunity: a systematic review.Autoimmune cytopenia in chronic lymphocytic leukaemia: diagnosis and treatment.The use of monoclonal antibodies in the treatment of autoimmune complications of chronic lymphocytic leukemia.Autoimmune cytopenias in chronic lymphocytic leukemia, facts and mythsPoor efficacy and tolerability of R-CHOP in relapsed/refractory chronic lymphocytic leukemia and Richter transformation.A Concise Review of Autoimmune Cytopenias in Chronic Lymphocytic Leukemia.A case of primary ovarian lymphoma with autoimmune hemolytic anemia achieving complete response with Rituximab-based combination chemotherapy.Anti-CD20 monoclonal antibodies and their use in adult autoimmune hematological disorders.Rituximab for chronic lymphocytic leukemia.Anti-CD20 monoclonal antibodies in chronic lymphocytic leukemia.Current approaches for the treatment of autoimmune hemolytic anemia.Mechanisms of Resistance to Targeted Therapies in Chronic Lymphocytic Leukemia.Bendamustine and rituximab combination in the management of chronic lymphocytic leukemia-associated autoimmune hemolytic anemia: a multicentric retrospective study of the French CLL intergroup (GCFLLC/MW and GOELAMS).Bendamustine plus rituximab for indolent B-cell lymphoma of renal significance.Rituximab-cyclophosphamide-dexamethasone combination in management of autoimmune cytopenias associated with chronic lymphocytic leukemia.How I treat patients with relapsed chronic lymphocytic leukaemia.Salvage therapy of Autoimmune Thrombocytopenic Purpura revealing non-Hodgkin Lymphoma by the thrombopoietin receptor agonist romiplostim
P2860
Q27312086-8E870243-30D1-414D-9166-F6972D1615ABQ30417730-E94B5FA3-B9EF-4F77-9FB0-8EE2A933C18FQ30855660-990BCFCD-4D03-4B41-96E5-54FBF0072DC6Q33384585-67CC90BB-A9C3-40BB-B5DA-2C8890947AF1Q33388795-114C077D-97C4-4658-B8C9-28B2E7D9E698Q33389022-7E15EA12-65D9-431A-965C-8E1244D0A2FDQ33390656-F28C5A7D-9851-4E93-8BFE-B634E774B9B1Q33393126-F9251223-1779-4619-ADE2-74322D573A2FQ33393696-08D674F0-97D9-455D-9C21-C881BD38BAD3Q33395141-A4395389-45D7-45AA-B7DF-64DD8D58FB8BQ33407700-EA7B7F9B-FF78-4FFD-A824-517BC043F78AQ33412266-A481CE73-BA90-42F9-BF62-63574AD89F74Q33417548-985F3524-988C-426B-BE13-678A55D38507Q33439333-E999C5B5-92D3-4714-80C0-396E06258AFEQ35931544-12539766-3E02-4230-8C36-257991AC7399Q37843939-129D31A9-3630-4364-A131-FC1632918522Q37988562-475CB305-DBCB-4064-8D2F-13FC9E203235Q38068932-D7523D72-21F0-42EE-AE99-142C9C4C55D0Q38108152-EC982D0C-AE46-4556-92A4-BF3CD1E77903Q39169789-52804A0C-3654-4127-AA7C-41443BC01BD4Q44606244-6F310CBE-1562-43A9-8484-B7A864EEC429Q48248578-2440B702-9FC0-4B4C-B60D-276E7A079468Q50531431-8E34624F-D019-4CDD-8791-6FDB15E380F9Q54348577-BBACDB96-CA6C-48CA-A841-8E23C2E87E26Q57217530-DB0E17AB-42D6-48A3-BDBF-F85C7E59019B
P2860
A combination of rituximab, cyclophosphamide and dexamethasone effectively treats immune cytopenias of chronic lymphocytic leukemia.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
A combination of rituximab, cy ...... chronic lymphocytic leukemia.
@ast
A combination of rituximab, cy ...... chronic lymphocytic leukemia.
@en
type
label
A combination of rituximab, cy ...... chronic lymphocytic leukemia.
@ast
A combination of rituximab, cy ...... chronic lymphocytic leukemia.
@en
prefLabel
A combination of rituximab, cy ...... chronic lymphocytic leukemia.
@ast
A combination of rituximab, cy ...... chronic lymphocytic leukemia.
@en
P2093
P2860
P921
P1433
P1476
A combination of rituximab, cy ...... chronic lymphocytic leukemia.
@en
P2093
Angelica Caramanica
Christina Johnson
Dilip Patel
Matthew Kaufman
Nancy Driscoll
Sewanti A Limaye
Yehuda Lebowicz
P2860
P304
P356
10.1080/10428190902887563
P577
2009-06-01T00:00:00Z